Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study
Open Access
- 1 July 2020
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 31 (5), 496-505
- https://doi.org/10.1111/pai.13237
Abstract
Background There are sparse real-world data on severe asthma exacerbations (SAE) in children. This multinational cohort study assessed the incidence of and risk factors for SAE and the incidence of asthma-related rehospitalization in children with asthma. Methods Asthma patients 5-17 years old with >= 1 year of follow-up were identified in six European electronic databases from the Netherlands, Italy, the UK, Denmark and Spain in 2008-2013. Asthma was defined as >= 1 asthma-specific disease code within 3 months of prescriptions/dispensing of asthma medication. Severe asthma was defined as high-dosed inhaled corticosteroids plus a second controller. SAE was defined by systemic corticosteroids, emergency department visit and/or hospitalization all for reason of asthma. Risk factors for SAE were estimated by Poisson regression analyses. Results The cohort consisted of 212 060 paediatric asthma patients contributing to 678 625 patient-years (PY). SAE rates ranged between 17 and 198/1000 PY and were higher in severe asthma and highest in severe asthma patients with a history of exacerbations. Prior SAE (incidence rate ratio 3-45) and younger age increased the SAE risk in all countries, whereas obesity, atopy and GERD were a risk factor in some but not all countries. Rehospitalization rates were up to 79% within 1 year. Conclusions In a real-world setting, SAE rates were highest in children with severe asthma with a history of exacerbations. Many severe asthma patients were rehospitalized within 1 year. Asthma management focusing on prevention of SAE is important to reduce the burden of asthma.Keywords
Funding Information
- ZonMw (113201006)
- GlaxoSmithKline (PRJ2284)
This publication has 32 references indexed in Scilit:
- Increasing scientific standards, independence and transparency in post‐authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and PharmacovigilancePharmacoepidemiology and Drug Safety, 2012
- The association of obesity and asthma severity and control in childrenJournal of Allergy and Clinical Immunology, 2011
- The prevalence of asthma and COPD in Italy: A practice-based studyRespiratory Medicine, 2011
- Existing data sources for clinical epidemiology: Aarhus University Prescription DatabaseClinical Epidemiology, 2010
- The occupational contribution to severe exacerbation of asthmaEuropean Respiratory Journal, 2010
- Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyJournal of Allergy and Clinical Immunology, 2009
- Recent asthma exacerbations: A key predictor of future exacerbationsRespiratory Medicine, 2007
- Asthma treatment needs: A comparison of patients' and health care professionals' perceptionsClinical Therapeutics, 2004
- A Cox Regression Analysis of Covariates for Asthma Hospital ReadmissionsJournal of Asthma, 2003
- Changing patterns of hospital admission for asthma, 1981-97Thorax, 2001